$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Pulsatile drug delivery system 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/26
  • A61K-009/58
  • A61K-009/60
  • A61K-009/62
출원번호 US-0857105 (1997-05-15)
발명자 / 주소
  • Bai Jane Pei-Fan
출원인 / 주소
  • BioAdvances LLC
대리인 / 주소
    Synnestvedt & Lechner
인용정보 피인용 횟수 : 250  인용 특허 : 0

초록

A pulsatile drug delivery system comprising of a plurality of particles is able to deliver drug in any desired patterns. A plurality of particles with multi-layer core capable of short-pulse release interlaced with long-duration release is designed for delivery of multi-agents simultaneously or sequ

대표청구항

[ What is claimed is:] [1.] A pulsatile drug delivery system for the release of an active medicament in pulsed dosages when exposed to an aqueous environment which comprises one or more groups of particles which contain the active medicament, enclosed in a solid dosage form, with each of said groups

이 특허를 인용한 특허 (250)

  1. Knight, James; Cartt, Steve; Young, David; Becker, Patrice, ACTH for treatment of acute respiratory distress syndrome.
  2. Cartt, Steve; Gong, Rujun, ACTH prophylactic treatment of renal disorders.
  3. Cartt, Steve; Gong, Rujun, ACTH prophylactic treatment of renal disorders.
  4. Schmidt,Mattias; Meyer,Axel; Fossum,Renae Dianna; Goldman,Stephen Allen; Urankar,Edward Joseph; Ehrnsperger,Bruno Johannes, Absorbent article comprising coated water-swellable material.
  5. Schmidt,Mattias; Meyer,Axel; Fossum,Renae Dianna; Ehrnsperger,Bruno Johannes; Goldman,Stephen Allen; Divo,Michael; Urankar,Edward Joseph, Absorbent article comprising coated water-swellable polymer.
  6. Beruda, Holger; Nakagawa, Yasue; Link, Andrea Lieselotte; Schmidt, Mattias, Absorbent articles comprising fluid acquisition zones with superabsorbent polymers.
  7. Schmidt, Mattias; Meyer, Axel; Fossum, Renae Dianna; Autran, Jean-Philippe Marie; Riegel, Ulrich; Daniel, Thomas; Bruhns, Stefan; Elliott, Mark; Haeberle, Karl, Absorbent structure with improved water-absorbing material comprising polyurethane, coalescing aid and antioxidant.
  8. Fossum, Renae Dianna; Schmidt, Mattias; Meyer, Axel, Absorbent structures comprising coated water-swellable material.
  9. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  10. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  11. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  12. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment.
  13. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  14. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  15. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  16. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and anti-inflammation methods.
  17. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  18. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  19. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  20. Tseng, Scheffer; He, Hua; Li, Wei, Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition.
  21. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Amoxicillin-clarithromycin antibiotic composition.
  22. Rudnic, Edward M.; Isbiter, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Amoxicillin-dicloxacillin antibiotic composition.
  23. Chen, Isan; Hager, Jeffrey H; Maneval, Edna Chow; Herbert, Mark R; Smith, Nicholas D, Androgen receptor modulator and uses thereof.
  24. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  25. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  26. Smith, Nicholas D.; Bonnefous, Celine; Julien, Jackaline D., Androgen receptor modulators and uses thereof.
  27. Chen, Isan, Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer.
  28. Chen, Isan, Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer.
  29. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Anti-fungal composition.
  30. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic composition.
  31. Rudnic, Edward M., Antibiotic composition with inhibitor.
  32. Rudnic,Edward M., Antibiotic composition with inhibitor.
  33. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  34. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  35. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  36. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  37. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  38. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  39. Burnside, Beth A.; Flanner, Henry H.; Rowlings, Colin, Antibiotic product, use and formulation thereof.
  40. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  41. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  42. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antibiotic product, use and formulation thereof.
  43. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Antiviral product, use and formulation thereof.
  44. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  45. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Antiviral product, use and formulation thereof.
  46. Haldar, Rama; Zamora, John; Ray, Dipan B.; Drefko, William; Dubrowny, Greg; Etienne, Sidney, Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability.
  47. Foreman, Paul B.; Richardson, Paul; Tsai, John; Remon, Jean Paul; Voorspoels, Jody; Ameye, Dieter; Callens, Catherine, Bioadhesive composition.
  48. Marchant Nancy S. ; Yu Simon Hsaio-Pao ; Amjad Zahid, Bioadhesive polymer compositions.
  49. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Cephalosporin-metronidazole antibiotic composition.
  50. Albert,Kenneth Stephen; Maes,Paul Jos챕, Chronotherapeutic diltiazem formulations and the administration thereof.
  51. Baichwal, Anand R.; Woodcook, Paul; Higgins, Raymond; Cobb, Jaclyn, Chronotherapeutic dosage forms and methods of treatment using chronotherapy.
  52. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Ciprofoxacin-metronidazole antibiotic composition.
  53. Sukhishvili, Svetlana; Pavlukhina, Svetlana, Clay-containing thin films as carriers of absorbed molecules.
  54. Schmidt, Mattias; Meyer, Axel; Ehrnsperger, Bruno Johannes; Goldman, Stephen Allen; Urankar, Edward Joseph, Coated water-swellable material.
  55. Schmidt,Mattias; Meyer,Axel; Ehrnsperger,Bruno Johannes; Goldman,Stephen Allen; Urankar,Edward Joseph, Coated water-swellable material.
  56. Schmidt, Mattias; Meyer, Axel; Ehrnsperger, Bruno Johannes; Goldman, Stephen Allen; Urankar, Edward Joseph, Coated water-swellable material comprising hydrogel forming polymers.
  57. Schmidt,Mattias; Meyer,Axel; Ehrnsperger,Bruno Johannes; Goldman,Stephen Allen; Urankar,Edward Joseph, Coated water-swellable material comprising hydrogel-forming polymeric core and polymeric coating agent.
  58. Sharma, Vinay K.; Hussain, Javed; Khorakiwala, Habil F., Composition for pulsatile delivery of diltiazem and process of manufacture.
  59. Flanner, Henry H.; Guttendorf, Robert J.; Clausen, Susan P.; Treacy, Donald; Burnside, Beth A., Compositions and methods for improved efficacy of penicillin-type antibiotics.
  60. Tseng, Scheffer; He, Hua, Compositions containing HC-HA complex and methods of use thereof.
  61. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  62. Tseng, Scheffer; He, Hua; Tighe, Sean; Zhang, Suzhen; Zhu, Ying-Tieng, Compositions containing HC-HA/PTX3 complexes and methods of use thereof.
  63. Tseng, Scheffer; Chua, Lorraine, Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof.
  64. Burns Patrick J. ; Gibson John W. ; Tipton Arthur J., Compositions suitable for controlled release of the hormone GnRH and its analogs.
  65. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  66. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  67. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  68. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael S.; Bratin, Karl; Shanker, Ravi M., Compositions with a rheological modifier to reduce dissolution variability.
  69. Simon, Julian; Johnson, Graham; Rubel, Edwin; Raible, David; Gonzalez, Mario D.; Meltzer, Peter C.; Miao, Weishi, Compounds and methods for preventing or treating sensory hair cell death.
  70. Simon, Julian; Johnson, Graham; Rubel, Edwin; Chowdhury, Sarwat; Herr, R. Jason; Jiang, Qin; Chen, Xinchao; Owens, Kelly N.; Raible, David, Compounds and methods for preventing, treating and/or protecting against sensory hair cell death.
  71. Simon, Julian; Johnson, Graham; Rubel, Edwin; Chowdhury, Sarwat; Herr, R. Jason; Jiang, Qin; Chen, Xinchao; Owens, Kelly N; Raible, David, Compounds and methods for preventing, treating and/or protecting against sensory hair cell death.
  72. Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Rogers, Evan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  73. Rogers, Evan; Cao, Jianguo; Wang, Zhijun; Grey, Jonathan; Whitten, Jeffrey P., Compounds that modulate intracellular calcium.
  74. Verity, A. Neil, Controlled delivery system.
  75. Verity, A. Neil, Controlled delivery system.
  76. Verity, A. Neil, Controlled delivery system.
  77. Verity, A. Neil, Controlled delivery system.
  78. Odidi, Isa; Odidi, Amina, Controlled extended drug release technology.
  79. Odidi, Isa; Odidi, Amina, Controlled release delivery device comprising an organosol coat.
  80. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone.
  81. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  82. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  83. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  84. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  85. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  86. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  87. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  88. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  89. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  90. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  91. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  92. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K.; Tonelli, Alfred, Controlled release hydrocodone formulations.
  93. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Controlled release hydrocodone formulations.
  94. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  95. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Controlled release hydrocodone formulations.
  96. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  97. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  98. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  99. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  100. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  101. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  102. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred P., Controlled release hydrocodone formulations.
  103. Venkatesh, Gopi; Kramer, Craig, Controlled release potassium chloride tablets.
  104. Guo, Jian-Hwa, Controlled release solid dosage carbamazepine formulations.
  105. Baichwal, Anand R.; Woodcock, Paul; Higgins, Raymond; Cobb, Jaclyn, Delayed release dosage forms.
  106. Penhasi, Adel; Flashner, Moshe; Lerner, E. Itzhak, Delayed total release two pulse gastrointestinal drug delivery system.
  107. Jodaikin, Aharon; Jodaikin, Hilary, Device for fixation at a dental site.
  108. Cheng, Xiu Xiu; Qi, Xiaohong; Zhang, Guohua; Dixit, Manesh, Diltiazem controlled release formulation and method of manufacture.
  109. Edgren David E. ; Skluzacek Robert R., Dosage form having first and second coats.
  110. Venkatesh, Gopi; Lai, Jin-Wang; Vyas, Nehal H.; Purohit, Vivek, Drug delivery systems comprising weakly basic drugs and organic acids.
  111. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Erythromyacin antibiotic product, use and formulation thereof.
  112. Bangera, Mahalaxmi Gita; Boyden, Edward S.; Hyde, Roderick A.; Ishikawa, Muriel Y.; Rivet, Dennis J.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Ex vivo modifiable multiple medicament final dosage form.
  113. Huang, Yun-Peng; Lee, Fangchan; Shaw, Jer-Yen, Excipients containing low residual solvent and method for producing the same.
  114. Venkatesh, Gopi M.; Vishnupad, Krishna S.; Percel, Phillip J., Extended release dosage forms of propranolol hydrochloride.
  115. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  116. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  117. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  118. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Fluroquinilone antibiotic product, use and formulation thereof.
  119. Kumar, Ravi Seshagirirao, Formulations and methods for treatment of metabolic syndrome.
  120. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses thereof.
  121. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses thereof.
  122. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram, Formulations of histone deacetylase inhibitor and uses therof.
  123. Loury, David J.; Buggy, Joseph J.; Mody, Tarak D.; Verner, Erik J.; Purro, Norbert; Balasubramanian, Sriram; Kloos, Ioana; Depil, Stephane, Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof.
  124. Jaklenec, Ana; Xu, Xian; Wood, Jr., Lowell L.; Eckhoff, Philip A.; Gates, William; Nikolic, Boris; Langer, Robert S., Fortified micronutrient salt formulations.
  125. Berner, Bret; Louie-Helm, Jenny; Shell, John W., Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract.
  126. Berner, Bret; Louie-Helm, Jenny; Shell, John W., Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract.
  127. Ralph W. Blume ; Robert D. Davis ; Donald Jeffrey Keyser, Guaifenesin sustained release formulation and tablets.
  128. Gibson, John W.; Miller, Stacey S.; Middleton, John C.; Tipton, Arthur J., High viscosity liquid controlled delivery system and medical or surgical device.
  129. John W. Gibson ; Stacey A. Sullivan ; John C. Middleton ; Arthur J. Tipton, High viscosity liquid controlled delivery system and medical or surgical device.
  130. Frate, Dean M.; Guo, Jian-Hwa, Hydrogels containing substances.
  131. MacGregor, Alexander, Hydrostatic delivery system for controlled delivery of agent.
  132. MacGregor,Alexander, Hydrostatic delivery system for controlled delivery of agent.
  133. Beaton, Graham; Tucci, Fabio; Ravula, Satheesh B.; Wang, Hua-Yu, Inhibition of OLIG2 activity.
  134. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  135. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  136. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  137. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Levofloxacin antibiotic product, use and formulation thereof.
  138. Shaw, Kenneth; Zhang, Mingbao, Liquid ganaxolone formulations and methods for the making and use thereof.
  139. Shaw, Kenneth; Zhang, Mingbao, Liquid ganaxolone formulations and methods for the making and use thereof.
  140. Whitbourne, Richard J.; Chamberlain, Alexandra M.; Hullihen, Daniel G.; Rosebrough, Scott F.; Calistri-Yeh, Mildred, Medicated stent having multi-layer polymer coating.
  141. Whitbourne, Richard J.; Chamberlain, Alexandra M.; Hullihen, Daniel G.; Rosebrough, Scott F.; Calistri-Yeh, Mildred, Medicated stent having multi-layer polymer coating.
  142. Shawn T. Huxel ; Ram L. Kataria ; Joel S. Rosenblatt, Method and composition for deforming soft tissues.
  143. Adimoolam, Shanthi; Buggy, Joseph J.; Magda, Darren; Miller, Richard, Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy.
  144. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
  145. Vargas Rincon, Ricardo Alberto; Reiz, Joseph, Methods and compositions particularly for treatment of attention deficit disorder.
  146. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of manufacturing oral dosage forms.
  147. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of manufacturing oral formulations.
  148. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  149. Tseng, Scheffer; Tan, Ek Kia; He, Hua, Methods of modulating bone remodeling.
  150. Tseng, Scheffer; Tan, Ek Kia; Chua, Lorraine, Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof.
  151. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John K; Tonelli, Alfred, Methods of providing analgesia.
  152. Oshlack, Benjamin; Huang, Hua-Pin; Masselink, John; Tonelli, Alfred, Methods of providing analgesia.
  153. Jonas, Jeffrey; Bose, Anjana; Tsai, Joyce, Methods of treating central nervous system disorders with a low dose combination of escitalopram and bupropion.
  154. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Metronidazole antibiotic product, use and formulation thereof.
  155. Flanner, Henry H.; Tolle-Sander, Sanna; Treacy, Donald; Burnside, Beth A.; Clausen, Susan P., Modified release amoxicillin products.
  156. Devane, John G.; Stark, Paul; Fanning, Niall M. M., Multiparticulate modified release composition.
  157. Devane, John G.; Stark, Paul; Fanning, Niall M. M.; Rekhi, Gurvinder Singh, Multiparticulate modified release composition.
  158. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release anti-neoplastic product, use and formulation thereof.
  159. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release anti-viral product, use and formulation thereof.
  160. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed release antifungal product, use and formulation thereof.
  161. Rudnic,Edward M.; Isbister,James D.; Treacy, Jr.,Donald J.; Wassink,Sandra E., Multiple-delayed released antibiotic product, use and formulation thereof.
  162. Devane, John G; Stark, Paul; Fanning, Niall M. N.; Rekhi, Gurvinder Singh; Jenkins, Scott A.; Liversidge, Gary, Nanoparticulate and controlled release compositions comprising cefditoren.
  163. Rudnic, Edward M; Isbister, James D; Treacy, Jr., Donald J; Wassink, Sandra E, Once a day amoxicillin product comprising immediate and delayed release dosage forms.
  164. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  165. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  166. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  167. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  168. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  169. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C., Oral drug delivery system.
  170. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  171. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  172. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  173. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  174. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  175. Yum, Su Il; Schoenhard, Grant; Tipton, Arthur J.; Gibson, John W.; Middleton, John C.; Fu, Roger; Zamloot, Michael S., Oral drug delivery system.
  176. Odidi, Isa; Odidi, Amina, Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors.
  177. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharamaceutical dosage forms.
  178. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  179. Scicinski, Jan J.; van Osdol, William W.; Su, Huey-Ching; Arenberg, Michael H.; Shah, Jaymin, Oral pharmaceutical dosage forms.
  180. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  181. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  182. Yum, Su Il; Chao, Wendy; Su, Huey-Ching; Fu, Roger; Zamloot, Michael, Oral pharmaceutical dosage forms.
  183. Kamal K. Midha BM; Mark Hirsh ; Whe-Yong Lo, Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent.
  184. Midha, Kamal K.; Hirsh, Mark; Lo, Whe-Yong, Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent.
  185. Burnside Beth A. ; Guo Xiaodi ; Fiske Kimberly ; Couch Richard A. ; Treacy Donald J. ; Chang Rong-Kun ; McGuinness Charlotte ; Rudnic Edward M., Oral pulsed dose drug delivery system.
  186. Burnside, Beth A.; Guo, Xiaodi; Fiske, Kimberly; Couch, Richard A.; Chang, Rong-Kun; Treacy, Donald J.; McGuiness, Charlotte M.; Rudnic, Edward M., Oral pulsed dose drug delivery system.
  187. Burnside, Beth A.; Guo, Xiaodi; Fiske, Kimberly; Couch, Richard A.; Treacy, Donald J.; Chang, Rong-Kun; McGuinness, Charlotte M.; Rudnic, Edward M., Oral pulsed dose drug delivery system.
  188. Burnside, Beth A.; Guo, Xiaodi; Fiske, Kimberly; Couch, Richard A.; Treacy, Donald J.; Chang, Rong-Kun; Rudnic, Edward M.; McGuinness, Charlotte M., Oral pulsed dose drug delivery system.
  189. Talwar Naresh,INX ; Sen Himadri,INX ; Staniforth John N.,GBX, Orally administered controlled drug delivery system providing temporal and spatial control.
  190. Talwar, Naresh; Sen, Himadri; Staniforth, John N., Orally administered drug delivery system providing temporal and spatial control.
  191. Venkatesh, Gopi M.; Harmon, Troy M.; Taylor, John, Orally disintegrating tablets of atomoxetine.
  192. Stappenbeck, Frank; Fan, Yi Chiao, Oxysterols and hedgehog signaling.
  193. Kim Hyun-Soo,KRX ; Park Young-Joon,KRX ; Jo Hang-Bum,KRX, Pharmaceutical capsule compositions containing loratadine and psuedoephedrine.
  194. Odidi, Isa; Odidi, Amina, Pharmaceutical composition having reduced abuse potential.
  195. Flanner, Henry H.; Guttendorf, Robert; Treacy, Donald; Clausen, Susan P.; Burnside, Beth A., Pharmaceutical compositions and methods for improved bacterial eradication.
  196. Han, Chien-Hsuan; Hsu, Larry; Hsu, Ann F., Pharmaceutical dosage forms having immediate release and/or controlled release properties.
  197. Christof Jaenicke DE; Jorg Grunwald DE; Benedikt Hanggi CH, Pharmaceutical with predetermined activity profile.
  198. Richard Ting ; Charles Hsiao, Press coated, pulsatile drug delivery system suitable for oral administration.
  199. Ting, Richard; Hsiao, Charles, Press coated, pulsatile drug delivery system suitable for oral administration.
  200. Schmidt, Mattias; Meyer, Axel; Fossum, Renae Dianna; Ehrnsperger, Bruno Johannes; Goldman, Stephen Allen; Divo, Michael; Urankar, Edward Joseph, Process for making water-swellable material comprising coated water-swellable polymers.
  201. Schmidt, Mattias; Meyer, Axel; Fossum, Renae Dianna; Goldman, Stephen Allen; Urankar, Edward Joseph; Ehmsperger, Bruno Johannes, Process for making water-swellable material comprising coated water-swellable polymers.
  202. Schmidt,Mattias; Meyer,Axel; Fossum,Renae Dianna; Goldman,Stephen Allen; Urankar,Edward Joseph; Ehrnsperger,Bruno Johannes, Process for making water-swellable material comprising coated water-swellable polymers.
  203. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  204. Odidi, Isa; Odidi, Amina, Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient.
  205. Weinbach, Susan; Tillman, Lloyd G.; Geary, Richard S.; Hardee, Gregory E., Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption.
  206. Percel, Philip J.; Vyas, Nehal H.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Pulsatile release histamine H2 antagonist dosage form.
  207. Odidi, Isa; Odidi, Amina, Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems.
  208. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  209. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  210. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  211. Tseng, Scheffer; He, Hua; Li, Wei, Purified amniotic membrane compositions and methods of use.
  212. Chen, Wei; Loury, David J., Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors.
  213. Jodaikin, Ahron; Jodaikin, Hilary, Reshapable device for fixation at a dental site.
  214. Cao, Bruce X.; Burnside, Beth A.; Wassink, Sandra E.; Baker, Matt R., Robust pellet.
  215. Shaw, Kenneth; Zhang, Mingbao, Solid ganaxolone formulations and methods for the making and use thereof.
  216. Shaw, Kenneth; Zhang, Mingbao, Solid ganaxolone formulations and methods for the making and use thereof.
  217. Shaw, Kenneth; Zhang, Mingbao, Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof.
  218. Shaw, Kenneth; Zhang, Mingbao, Stable corticosteroid nanoparticulate formulations and methods for the making and use thereof.
  219. Libera, Matthew R., Surfaces differentially adhesive to eukaryotic cells and non-eukaryotic cells.
  220. Couch, Richard A.; Burnside, Beth A.; Chang, Rong-Kun, Sustained release delivery of amphetamine salts.
  221. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release formulations of guaifenesin and additional drug ingredients.
  222. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release formulations of guaifenesin and additional drug ingredients.
  223. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin.
  224. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin combination drugs.
  225. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin combination drugs.
  226. Singh Shiva P.,INX ; Mukarram Siddiqui Mohammed Jaweed,INX ; Kulkami Dilip Ganesh,INX ; Purohit Manish,INX, Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole.
  227. Li, Chunhua; Carlyle, Wenda C.; De Smedt, Philippe; Abolfathi, Amir; Kuo, Eric E.; Tricca, Robert E.; Chen, Jennifer C.; Wu, Benjamin M., Systems and methods for intra-oral drug delivery.
  228. Li, Chunhua; Carlyle, Wenda C.; De Smedt, Philippe; Abolfathi, Amir; Kuo, Eric E.; Tricca, Robert E.; Chen, Jennifer C.; Wu, Benjamin M., Systems and methods for intra-oral drug delivery.
  229. Cao, Bruce; Wassink, Sandra E.; Treacy, Jr., Donald J.; Burnside, Beth A.; Rowlings, Colin E.; Bonck, John A., Tablet for pulsed delivery.
  230. Whitbourne, Richard J.; Hullihen, Daniel; Violante, Michael R.; Wang, Frank Guo-Bin; Zhang, Xianping, Targeted therapeutic agent release devices and methods of making and using the same.
  231. Folger, Martin; Lehner, Stefan; Grave, Annette; Poellinger, Norbet; Seidler, Randolph, Taste masked pharmaceutical composition.
  232. Appel, Leah Elizabeth; Friesen, Dwayne Thomas; LaChapelle, Edward Dennis; Konagurthu, Sanjay; Falk, Richard Frank; Reo, Joseph P., Taste-masked drugs in rupturing multiparticulates.
  233. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  234. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  235. Hentrich, Dirk; Emmerling, Winfried; Flodrop, Helga van, Temperature-resistant styling medium.
  236. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Tetracycline antibiotic product, use and formulation thereof.
  237. Rudnic, Edward M.; Isbister, James D.; Treacy, Jr., Donald J.; Wassink, Sandra E., Tetracycline--doxycycline antibiotic composition.
  238. Percel, Phillip; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed pulsatile drug delivery systems.
  239. Percel,Phillip J.; Vishnupad,Krishna S.; Venkatesh,Gopi M.; Lee,Der Yang, Timed pulsatile drug delivery systems.
  240. Venkatesh, Gopi M., Timed, pulsatile release systems.
  241. Venkatesh, Gopi M., Timed, pulsatile release systems.
  242. Venkatesh, Gopi M., Timed, pulsatile release systems.
  243. Venkatesh, Gopi M., Timed, pulsatile release systems.
  244. Venkatesh, Gopi M., Timed, pulsatile release systems.
  245. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  246. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  247. Phillip J. Percel ; Krishna S. Vishnupad ; Gopi M. Venkatesh, Timed, sustained release systems for propranolol.
  248. Yum, Su II; Kwon, Sung Yun; Song, Xiaoping; Brown, James E., Transdermal delivery systems.
  249. Chen Chih-Ming ; Cheng Xiu Xiu, Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate.
  250. Fossum,Renae Dianna; Schmidt,Mattias; Meyer,Axel, Water-swellable material comprising coated water-swellable polymers.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로